Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen

scientific article published on 01 November 2000

Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0022-5347(05)67026-7
P698PubMed publication ID11025702

P2093author name stringPotts JM
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)1550-1553
P577publication date2000-11-01
P1433published inJournal of UrologyQ15709979
P1476titleProspective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen
P478volume164

Reverse relations

cites work (P2860)
Q35738225A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammation
Q28253200Acute and chronic prostatitis
Q40205416Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen
Q41934883Changes in the Normal Cellular Architecture in the Prostatic Tissue with the Increasing age.
Q35159825Chronic pelvic pain syndrome: a non-prostatocentric perspective
Q36456149Dealing with non-cancerous findings on prostate biopsy
Q34767678Diagnosing the prostatitis patient: the dilemma continues
Q55350987Differential expression patterns of housekeeping genes increase diagnostic and prognostic value in lung cancer.
Q49164947Do antibiotics decrease prostate-specific antigen levels and reduce the need for prostate biopsy in type IV prostatitis? A systematic literature review
Q36575823Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10 ng/mL?
Q36450786Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
Q53647769Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer.
Q39756197Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
Q37682420Inflammatory changes in biopsy specimens from patients with suspected prostate cancer
Q81133184Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study
Q37537786Management of elevated prostate-specific antigen in men with nonbacterial chronic prostatitis
Q80633099PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients
Q34767705Phytotherapy and other alternative forms of care for the patient with prostatitis
Q34775766Prevalence of asymptomatic inflammatory (National Institutes of Health Category IV) prostatitis in young men according to semen analysis
Q35151989Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis
Q37258897Prostate cancer and chronic prostatitis
Q35683035Prostate kallikrein markers in diagnosis, risk stratification and prognosis.
Q82405984Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome
Q24646945Prostatitis and male pelvic pain syndrome: diagnosis and treatment
Q35982328Prostatitis and prostate cancer: implications for prostate cancer screening
Q36174680Prostatitis and serum prostate-specific antigen
Q49091944Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases
Q83912941Seminal interleukin-6 and serum prostate-specific antigen as possible predictive biomarkers in asymptomatic inflammatory prostatitis
Q34239009The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
Q53097022The Effect of a Pure Anti-inflammatory Therapy on Reducing Prostate-specific Antigen Levels in Patients Diagnosed With a Histologic Prostatitis.
Q77291647The New Age of Prostatitis
Q81707729The case for prostate-specific antigen screening starting at age 40
Q37089968The effect of antibiotherapy on prostate-specific antigen levels and prostate biopsy results in patients with levels 2.5 to 10 ng/mL
Q28258235Therapeutic options for chronic prostatitis/chronic pelvic pain syndrome
Q80531033[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin]

Search more.